by Rachad Davis
April 21, 2016
Vice President, Advanced Analytics,
Dr. Teigland serves as Senior Director of Statistical Research for Inovalon where she leads a team of ten healthcare research professionals in the design and implementation of internal and external health outcomes research projects, including comparative effectiveness and pharmacoeconomic studies, risk modeling and predictive analytics, and performance measure development and testing. She serves as co-chair of the Pharmacy Quality Alliance (PQA) Measures Work Group and participates on the PQA Sociodemographic Risk Adjustment Advisory Group. Dr. Teigland has directed performance measure projects awarded by the National Committee on Quality Assurance (NCQA) and Heart Rhythm Society.
Prior to joining Inovalon, Dr. Teigland specialized in quality measurement and quality improvement research at the Foundation for Long Term Care in New York where she directed the development of innovative technology solutions to advance the use of data-driven decision making to improve outcomes and reduce healthcare costs. Dr. Teigland served as Principal Investigator for large grant funded studies, including an Agency for Healthcare Research and Quality (AHRQ) patient safety project that developed predictive risk alerts for adverse events common in the elderly population, along with patient centered risk profiles to guide preventive actions. She developed new quality of life measures for patients with dementia under two Alzheimer’s Association grants, including a predictive model to identify undetected pain.
Dr. Teigland has served on CMS expert panels including a CMS workgroup to improve the Five Star Rating System, participated in development and field-testing of the AHRQ CAHPS satisfaction and patient safety tools, and serves on the American Medical Director’s Association (AMDA) Technology Work Group.